ACONW — Aclarion Inc
NASDAQ · Healthcare · Health Information Services
$0.03
+$0.00 (+0.00%)
Aclarion Inc (ACONW) is a health information services company listed on NASDAQ. It is led by Brent Ness, based in 8181 Arista Place, Broomfield, CO, United States, 80021, with about 5 employees. Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Latest reported ACONW revenue for 2025-09-30 was $18.9K. Net income was -$1.7M. Revenue was down 2.0% from 2025-06-30 to 2025-09-30.
Use this ACONW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACONW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACONW SEC filings page. Lician reads the product cache first so this HTML stays unique to Aclarion Inc even when a live quote feed is slow.
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
ACONW Key Statistics
Market Cap
$0.00M
Volume
36
Previous Close
$0.03
Day Range
$0.03 – $0.03
EPS
-$7.48K
Revenue
$45.72K
Net Income
-$6.99M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-39.4%
Profit Margin
-15293.8%
Employees
5
ACONW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $45.72K | $75.40K | $60.44K | $60.29K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.99M | -$4.91M | -$7.48M | -$4.95M |
| EPS (Diluted) | -$7.48K | -$79.78K | -$19.61 | -$6.58 |
Total Assets
$2.12M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$453.66K
Operating Cash Flow
-$5.27M
Free Cash Flow
$0.00
Aclarion Inc Company Information
- CEO, President & Director
- Brent Ness
- Headquarters
- 8181 Arista Place, Broomfield, CO, United States, 80021
- Website
- www.aclarion.com
- Phone
- 833 275 2266
- IPO / Founded
- 2022-04-22
- Sector
- Healthcare
- Industry
- Health Information Services